Stanford team treats final patient in landmark stem cell therapy trial

(Medical Xpress) -- The Stanford University School of Medicine and Santa Clara Valley Medical Center treated the fifth patient in the Geron Corp-sponsored trial of a human embryonic-stem-cell-derived treatment for severe spinal cord injury on Nov. 16.

Read the whole article on Physorg

More from Physorg